Objective: To study the influence of bone marrow mesenchymal stem cells (MSC) on the proliferation and apoptosis of allogeneic peripheral B lymphocytes in vitro.
Methods: MSCs were isolated from the peripheral blood of healthy volunteer and cultured. B lymphocytes were isolated from another healthy volunteer and co-cultured with the MSCs at the B:MSC ratios of 50:1, 10:1, and 1:1 or with different concentrations of MSC supernatant (12.5%, 25%, and 50%) for 72 h, in the presence of antihuman IgM immunoglobulin goat antibodies (Anti-IgM) at a final concentration of 10 microg/mlL. The proliferation of B lymphocytes was analyzed with MTT assay. B lymphocytes and MSC were co-cultured at the ratio of 1:1 for 24 h or 48 h, with or without addition of Anti-IgM. Flow cytometric was used to detect the apoptosis of B lymphocytes.
Results: The A value of B lymphocytes co-cultured with MSCs at different ratios were 0.521 +/- 0.093, 0.418 +/- 0.103, and 0.365 +/- 0.114 respectively. The A values of Group10:1 and Ggroup1:1 were both significantly lower than that of the control group (0.679 +/- 0.049, both P < 0.01), and the A value of Ggroup1:1 was significantly lower than that of Group10:1 (P < 0.05). The A value of B lymphocytes co-cultured with 50% MSC supernatant was 0.504 +/- 0.099, significantly lower than those of the control group and Group 12.5% (both P < 0.05). MSCs didn't induce apoptosis of B lymphocytes. The apoptosis rates of B lymphocytes co-cultured with MSCs for 24 h or 48 h, in presence or absence of Anti-IgM were 1.90% +/- 0.75%, 2.33% +/- 1.01%, 2.33% +/- 0.75%, and 1.39% +/- 0.63% respectively, without significant difference between any 2 of the four groups.
Conclusion: MSC and its supernatant inhibit B lymphocyte proliferation with the mechanism correlated with the MSC concentration and the MSC-secreted cytokine, but MSCs does not induce B lymphocytes apoptosis in vitro.
Download full-text PDF |
Source |
---|
J Biol Eng
January 2025
Department of Traumatic Clinic, Shanghai East Hospital of Tongji University, Shanghai, 200120, China.
Objective: The direction of this study was to detect and analyze the specific mechanism of anti-apoptosis in mesenchymal stem cells (MSCs) cells caused by high expression of BCL2.
Methods: Bioinformatics was completed in Link omics. GO analysis and KEGG analysis were carried out, and the grope tool of Link omics database was used to evaluate PPI information and other core path analysis information.
Stem Cell Res Ther
January 2025
IRMB, Univ Montpellier, INSERM, CHU St Eloi, 80 AV A Fliche, 34295-Cedex-05, Montpellier, France.
Background: The regenerative potential of mesenchymal stromal/stem cells (MSCs) has been extensively studied in clinical trials in the past decade. However, despite the promising regenerative properties documented in preclinical studies, for instance in osteoarthritis (OA), the therapeutic translation of these results in patients has not been fully conclusive. One factor contributing to this therapeutic barrier could be the presence of senescent cells in OA joints.
View Article and Find Full Text PDFInt J Mol Sci
December 2024
IZKF Research Group Tissue Regeneration in Musculoskeletal Diseases, University Hospital Wuerzburg, D-97070 Wuerzburg, Germany.
Immunosuppression is one key feature of mesenchymal stromal cells (MSCs) that has high expectations for therapeutic use. The influence of pro-inflammatory stimuli can modify the characteristics of MSCs and enhance immunosuppressive properties. The local postoperative environment contains cytokines, MSCs, and immune cells in high quantities, and their mutual influence is still unclear.
View Article and Find Full Text PDFStem Cell Res Ther
January 2025
Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.
Background: Patient-derived lung cancer organoids (PD-LCOs) demonstrate exceptional potential in preclinical testing and serve as a promising model for the multimodal management of lung cancer. However, certain lung cancer cells derived from patients exhibit limited capacity to generate organoids due to inter-tumor or intra-tumor variability. To overcome this limitation, we have created an in vitro system that employs mesenchymal stromal cells (MSCs) or fibroblasts to serve as a supportive scaffold for lung cancer cells that do not form organoids.
View Article and Find Full Text PDFSheng Li Xue Bao
December 2024
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
The objective of the present study was to investigate the role and mechanism of bone marrow microenvironmental cells in regulating the mitochondrial mass of leukemia cells, and to uncover the mechanism of leukemia progression at the metabolic level. A mouse model of acute myeloid leukemia (AML) induced by the overexpression of the MLL-AF9 (MA9) fusion protein was established, and the bone marrow cells of AML mice were transplanted into mitochondrial fluorescence reporter mice expressing the Dendra2 protein (mito-Dendra2 mice). The proportion of Dendra2 cells in bone marrow leukemia cells at different stages of AML was quantified by flow cytometry.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!